Papua New Guinea

Papua New Guinea

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.2 (5.82 - 6.47) 2019 Modelled IHME
6.34 (5.98 - 6.62) 2018 Modelled IHME
6.45 (6.01 - 6.77) 2017 Modelled IHME
6.51 (5.98 - 6.85) 2016 Modelled IHME
6.58 (5.80 - 6.96) 2015 Modelled IHME
6.68 (5.87 - 7.07) 2014 Modelled IHME
6.82 (6.04 - 7.21) 2013 Modelled IHME
6.98 (6.24 - 7.37) 2012 Modelled IHME
7.15 (6.41 - 7.54) 2011 Modelled IHME
7.3 (6.55 - 7.72) 2010 Modelled IHME
7.46 (6.72 - 7.87) 2009 Modelled IHME
7.61 (6.84 - 8.04) 2008 Modelled IHME
7.77 (6.93 - 8.23) 2007 Modelled IHME
7.92 (7.04 - 8.41) 2006 Modelled IHME
8.06 (7.15 - 8.59) 2005 Modelled IHME
8.19 (7.19 - 8.73) 2004 Modelled IHME
8.31 (7.24 - 8.88) 2003 Modelled IHME
8.43 (7.31 - 9.02) 2002 Modelled IHME
8.55 (7.35 - 9.16) 2001 Modelled IHME
8.68 (7.40 - 9.34) 2000 Modelled IHME
8.81 (7.51 - 9.51) 1999 Modelled IHME
8.95 (7.57 - 9.69) 1998 Modelled IHME
9.09 (7.67 - 9.89) 1997 Modelled IHME
9.23 (7.77 - 10.10) 1996 Modelled IHME
9.36 (7.88 - 10.30) 1995 Modelled IHME
9.49 (7.96 - 10.43) 1994 Modelled IHME
9.63 (8.07 - 10.53) 1993 Modelled IHME
9.76 (8.20 - 10.64) 1992 Modelled IHME
9.9 (8.34 - 10.77) 1991 Modelled IHME
10.03 (8.40 - 10.92) 1990 Modelled IHME
5.4 (4.34 - 6.79) 2015 Modelled WHO
6.6 (6 - 7.70) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.57 (1.89 - 3.15) 2019 Modelled IHME
2.64 (1.91 - 3.20) 2018 Modelled IHME
2.66 (1.88 - 3.28) 2017 Modelled IHME
2.5 (1.63 - 3.09) 2016 Modelled IHME
2.33 (1.35 - 2.98) 2015 Modelled IHME
2.31 (1.35 - 2.95) 2014 Modelled IHME
2.3 (1.36 - 2.93) 2013 Modelled IHME
2.29 (1.38 - 2.91) 2012 Modelled IHME
2.29 (1.38 - 2.89) 2011 Modelled IHME
2.29 (1.40 - 2.90) 2010 Modelled IHME
2.28 (1.41 - 2.89) 2009 Modelled IHME
2.27 (1.43 - 2.89) 2008 Modelled IHME
2.27 (1.46 - 2.91) 2007 Modelled IHME
2.26 (1.47 - 2.93) 2006 Modelled IHME
2.27 (1.49 - 2.94) 2005 Modelled IHME
2.33 (1.57 - 3.05) 2004 Modelled IHME
2.48 (1.67 - 3.21) 2003 Modelled IHME
2.7 (1.81 - 3.44) 2002 Modelled IHME
2.95 (1.97 - 3.69) 2001 Modelled IHME
3.2 (2.12 - 4.02) 2000 Modelled IHME
3.49 (2.30 - 4.39) 1999 Modelled IHME
3.85 (2.53 - 4.86) 1998 Modelled IHME
4.23 (2.77 - 5.40) 1997 Modelled IHME
4.58 (3 - 5.87) 1996 Modelled IHME
4.87 (3.22 - 6.30) 1995 Modelled IHME
5.1 (3.40 - 6.51) 1994 Modelled IHME
5.31 (3.54 - 6.72) 1993 Modelled IHME
5.5 (3.71 - 6.92) 1992 Modelled IHME
5.67 (3.79 - 7.06) 1991 Modelled IHME
5.8 (3.86 - 7.22) 1990 Modelled IHME
2.24 (1.68 - 2.85) 2015 Modelled WHO
2.3 2013 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
409,904 (343,488 - 446,170) 1990 Modelled IHME
416,192 (350,604 - 452,978) 1991 Modelled IHME
422,712 (354,958 - 460,514) 1992 Modelled IHME
429,512 (360,088 - 469,758) 1993 Modelled IHME
436,602 (365,938 - 479,744) 1994 Modelled IHME
443,997 (373,867 - 488,479) 1995 Modelled IHME
451,497 (380,032 - 494,207) 1996 Modelled IHME
458,956 (387,387 - 499,372) 1997 Modelled IHME
466,367 (394,843 - 505,119) 1998 Modelled IHME
473,948 (404,192 - 511,742) 1999 Modelled IHME
481,951 (410,990 - 519,140) 2000 Modelled IHME
490,403 (421,840 - 525,630) 2001 Modelled IHME
499,136 (432,551 - 534,146) 2002 Modelled IHME
507,874 (442,616 - 542,315) 2003 Modelled IHME
516,328 (453,237 - 550,541) 2004 Modelled IHME
524,191 (464,639 - 558,158) 2005 Modelled IHME
531,151 (472,022 - 563,875) 2006 Modelled IHME
537,288 (479,045 - 568,902) 2007 Modelled IHME
542,890 (487,438 - 573,611) 2008 Modelled IHME
548,245 (494,034 - 578,801) 2009 Modelled IHME
553,678 (496,642 - 585,401) 2010 Modelled IHME
558,472 (501,105 - 589,073) 2011 Modelled IHME
562,259 (502,264 - 593,398) 2012 Modelled IHME
566,094 (500,827 - 598,097) 2013 Modelled IHME
571,164 (501,245 - 604,142) 2014 Modelled IHME
578,739 (510,589 - 612,538) 2015 Modelled IHME
589,962 (541,498 - 620,301) 2016 Modelled IHME
601,194 (560,720 - 630,781) 2017 Modelled IHME
608,255 (573,493 - 635,036) 2018 Modelled IHME
611,710 (574,412 - 638,804) 2019 Modelled IHME
535,000 (482,000 - 621,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.93 (2.02 - 4.16) 2019 Modelled IHME
2.94 (2 - 4.21) 2018 Modelled IHME
2.92 (1.98 - 4.17) 2017 Modelled IHME
2.89 (1.95 - 4.05) 2016 Modelled IHME
2.91 (1.97 - 4.13) 2015 Modelled IHME
2.89 (1.95 - 4.10) 2014 Modelled IHME
2.92 (1.96 - 4.17) 2013 Modelled IHME
2.98 (2 - 4.22) 2012 Modelled IHME
3.03 (2.02 - 4.26) 2011 Modelled IHME
3.03 (2.04 - 4.25) 2010 Modelled IHME
3.02 (2.02 - 4.23) 2009 Modelled IHME
3.09 (2.06 - 4.27) 2008 Modelled IHME
3.15 (2.13 - 4.38) 2007 Modelled IHME
3.17 (2.17 - 4.37) 2006 Modelled IHME
3.19 (2.18 - 4.42) 2005 Modelled IHME
3.18 (2.19 - 4.42) 2004 Modelled IHME
3.2 (2.20 - 4.47) 2003 Modelled IHME
3.22 (2.22 - 4.54) 2002 Modelled IHME
3.24 (2.21 - 4.58) 2001 Modelled IHME
3.28 (2.23 - 4.68) 2000 Modelled IHME
3.35 (2.29 - 4.80) 1999 Modelled IHME
3.37 (2.30 - 4.80) 1998 Modelled IHME
3.38 (2.30 - 4.82) 1997 Modelled IHME
3.43 (2.34 - 4.89) 1996 Modelled IHME
3.46 (2.36 - 4.96) 1995 Modelled IHME
3.53 (2.44 - 5.11) 1994 Modelled IHME
3.63 (2.53 - 5.23) 1993 Modelled IHME
3.74 (2.57 - 5.40) 1992 Modelled IHME
3.82 (2.66 - 5.50) 1991 Modelled IHME
3.9 (2.67 - 5.66) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
289 (200 - 410) 2019 Modelled IHME
282 (192 - 404) 2018 Modelled IHME
272 (185 - 389) 2017 Modelled IHME
262 (177 - 367) 2016 Modelled IHME
256 (173 - 363) 2015 Modelled IHME
247 (166 - 350) 2014 Modelled IHME
242 (163 - 346) 2013 Modelled IHME
240 (161 - 340) 2012 Modelled IHME
237 (158 - 333) 2011 Modelled IHME
230 (154 - 322) 2010 Modelled IHME
222 (149 - 311) 2009 Modelled IHME
220 (147 - 304) 2008 Modelled IHME
218 (147 - 303) 2007 Modelled IHME
213 (145 - 293) 2006 Modelled IHME
207 (142 - 288) 2005 Modelled IHME
201 (138 - 278) 2004 Modelled IHME
195 (135 - 273) 2003 Modelled IHME
191 (132 - 269) 2002 Modelled IHME
186 (127 - 263) 2001 Modelled IHME
182 (124 - 260) 2000 Modelled IHME
180 (123 - 258) 1999 Modelled IHME
176 (120 - 250) 1998 Modelled IHME
171 (116 - 243) 1997 Modelled IHME
168 (115 - 239) 1996 Modelled IHME
164 (112 - 235) 1995 Modelled IHME
163 (112 - 235) 1994 Modelled IHME
162 (113 - 233) 1993 Modelled IHME
162 (111 - 234) 1992 Modelled IHME
161 (112 - 231) 1991 Modelled IHME
159 (109 - 231) 1990 Modelled IHME
1,067 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
48 (39 - 59) 2019 Modelled IHME
48 (39 - 59) 2018 Modelled IHME
48 (39 - 59) 2017 Modelled IHME
48 (39 - 58) 2016 Modelled IHME
48 (39 - 58) 2015 Modelled IHME
48 (39 - 58) 2014 Modelled IHME
48 (38 - 58) 2013 Modelled IHME
48 (39 - 58) 2012 Modelled IHME
48 (38 - 58) 2011 Modelled IHME
48 (38 - 58) 2010 Modelled IHME
48 (39 - 58) 2009 Modelled IHME
48 (39 - 58) 2008 Modelled IHME
48 (39 - 58) 2007 Modelled IHME
48 (39 - 58) 2006 Modelled IHME
48 (39 - 58) 2005 Modelled IHME
48 (39 - 58) 2004 Modelled IHME
48 (39 - 58) 2003 Modelled IHME
48 (38 - 57) 2002 Modelled IHME
48 (38 - 57) 2001 Modelled IHME
48 (38 - 57) 2000 Modelled IHME
48 (38 - 57) 1999 Modelled IHME
48 (38 - 57) 1998 Modelled IHME
48 (39 - 58) 1997 Modelled IHME
48 (38 - 58) 1996 Modelled IHME
48 (39 - 58) 1995 Modelled IHME
49 (39 - 59) 1994 Modelled IHME
49 (39 - 59) 1993 Modelled IHME
49 (40 - 59) 1992 Modelled IHME
49 (40 - 59) 1991 Modelled IHME
50 (40 - 60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
25 2018 Survey/reported WHO/UNICEF
33 2017 Survey/reported WHO/UNICEF
35 2016 Survey/reported WHO/UNICEF
32 2015 Survey/reported WHO/UNICEF
31 2014 Survey/reported WHO/UNICEF
37 2013 Survey/reported WHO/UNICEF
35 2012 Survey/reported WHO/UNICEF
31 2011 Survey/reported WHO/UNICEF
31 2010 Survey/reported WHO/UNICEF
26 2009 Survey/reported WHO/UNICEF
27 2008 Survey/reported WHO/UNICEF
29 2007 Survey/reported WHO/UNICEF
35 2006 Survey/reported WHO/UNICEF
25 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
61 2018 Survey/reported WHO/UNICEF
62 2017 Survey/reported WHO/UNICEF
72 2016 Survey/reported WHO/UNICEF
73 2015 Survey/reported WHO/UNICEF
73 2014 Survey/reported WHO/UNICEF
79 2013 Survey/reported WHO/UNICEF
74 2012 Survey/reported WHO/UNICEF
72 2011 Survey/reported WHO/UNICEF
67 2010 Survey/reported WHO/UNICEF
66 2009 Survey/reported WHO/UNICEF
59 2008 Survey/reported WHO/UNICEF
61 2007 Survey/reported WHO/UNICEF
71 2006 Survey/reported WHO/UNICEF
63 2005 Survey/reported WHO/UNICEF
60 2004 Survey/reported WHO/UNICEF
67 2003 Survey/reported WHO/UNICEF
60 2002 Survey/reported WHO/UNICEF
59 2001 Survey/reported WHO/UNICEF
57 2000 Survey/reported WHO/UNICEF
54 1999 Survey/reported WHO/UNICEF
47 1998 Survey/reported WHO/UNICEF
44 1997 Survey/reported WHO/UNICEF
43 1996 Survey/reported WHO/UNICEF
23 1995 Survey/reported WHO/UNICEF
20 1994 Survey/reported WHO/UNICEF
7 1993 Survey/reported WHO/UNICEF
12 1992 Survey/reported WHO/UNICEF
19 1991 Survey/reported WHO/UNICEF
20 1990 Survey/reported WHO/UNICEF
35 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.01 (0.81 - 1.26) 2019 Modelled IHME
1.01 (0.80 - 1.26) 2018 Modelled IHME
1.01 (0.80 - 1.28) 2017 Modelled IHME
1.01 (0.81 - 1.26) 2016 Modelled IHME
1.01 (0.81 - 1.24) 2015 Modelled IHME
1.01 (0.81 - 1.25) 2014 Modelled IHME
1.02 (0.82 - 1.27) 2013 Modelled IHME
1.04 (0.83 - 1.29) 2012 Modelled IHME
1.06 (0.83 - 1.32) 2011 Modelled IHME
1.07 (0.84 - 1.35) 2010 Modelled IHME
1.09 (0.86 - 1.36) 2009 Modelled IHME
1.11 (0.89 - 1.38) 2008 Modelled IHME
1.14 (0.92 - 1.40) 2007 Modelled IHME
1.17 (0.94 - 1.43) 2006 Modelled IHME
1.2 (0.97 - 1.47) 2005 Modelled IHME
1.25 (1.01 - 1.52) 2004 Modelled IHME
1.3 (1.06 - 1.58) 2003 Modelled IHME
1.36 (1.11 - 1.66) 2002 Modelled IHME
1.42 (1.16 - 1.74) 2001 Modelled IHME
1.46 (1.19 - 1.81) 2000 Modelled IHME
1.5 (1.22 - 1.84) 1999 Modelled IHME
1.53 (1.25 - 1.87) 1998 Modelled IHME
1.56 (1.26 - 1.91) 1997 Modelled IHME
1.58 (1.26 - 1.94) 1996 Modelled IHME
1.59 (1.27 - 1.96) 1995 Modelled IHME
1.58 (1.26 - 1.93) 1994 Modelled IHME
1.54 (1.23 - 1.89) 1993 Modelled IHME
1.48 (1.18 - 1.82) 1992 Modelled IHME
1.4 (1.11 - 1.73) 1991 Modelled IHME
1.31 (1.03 - 1.63) 1990 Modelled IHME
1.2 (0.90 - 4.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
53,425 (42,235 - 66,664) 1990 Modelled IHME
58,841 (46,521 - 72,929) 1991 Modelled IHME
63,961 (50,965 - 78,945) 1992 Modelled IHME
68,589 (55,012 - 84,157) 1993 Modelled IHME
72,496 (58,013 - 88,716) 1994 Modelled IHME
75,424 (60,313 - 93,034) 1995 Modelled IHME
77,437 (61,845 - 94,894) 1996 Modelled IHME
78,874 (63,739 - 96,626) 1997 Modelled IHME
79,859 (65,255 - 97,669) 1998 Modelled IHME
80,577 (65,873 - 99,103) 1999 Modelled IHME
81,237 (66,334 - 100,637) 2000 Modelled IHME
81,380 (66,512 - 99,726) 2001 Modelled IHME
80,677 (65,887 - 98,187) 2002 Modelled IHME
79,565 (64,725 - 96,692) 2003 Modelled IHME
78,544 (63,466 - 95,693) 2004 Modelled IHME
78,184 (62,782 - 95,457) 2005 Modelled IHME
78,437 (63,056 - 95,924) 2006 Modelled IHME
78,855 (63,359 - 97,038) 2007 Modelled IHME
79,464 (63,311 - 98,334) 2008 Modelled IHME
80,285 (63,468 - 99,903) 2009 Modelled IHME
81,340 (63,859 - 102,468) 2010 Modelled IHME
82,469 (64,884 - 103,362) 2011 Modelled IHME
83,593 (66,630 - 103,932) 2012 Modelled IHME
84,883 (67,970 - 105,028) 2013 Modelled IHME
86,533 (69,434 - 106,638) 2014 Modelled IHME
88,749 (70,907 - 109,291) 2015 Modelled IHME
91,582 (73,047 - 113,739) 2016 Modelled IHME
94,503 (74,504 - 119,021) 2017 Modelled IHME
97,165 (77,211 - 121,274) 2018 Modelled IHME
99,687 (79,464 - 124,682) 2019 Modelled IHME
94,000 (70,000 - 328,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.94 (1.27 - 2.79) 2019 Modelled IHME
1.94 (1.28 - 2.76) 2018 Modelled IHME
1.93 (1.27 - 2.78) 2017 Modelled IHME
1.93 (1.28 - 2.74) 2016 Modelled IHME
1.95 (1.29 - 2.83) 2015 Modelled IHME
1.93 (1.28 - 2.80) 2014 Modelled IHME
1.92 (1.29 - 2.78) 2013 Modelled IHME
1.93 (1.29 - 2.77) 2012 Modelled IHME
1.92 (1.29 - 2.75) 2011 Modelled IHME
1.89 (1.26 - 2.71) 2010 Modelled IHME
1.84 (1.23 - 2.61) 2009 Modelled IHME
1.84 (1.24 - 2.60) 2008 Modelled IHME
1.83 (1.23 - 2.59) 2007 Modelled IHME
1.81 (1.21 - 2.57) 2006 Modelled IHME
1.81 (1.22 - 2.54) 2005 Modelled IHME
1.79 (1.20 - 2.53) 2004 Modelled IHME
1.79 (1.18 - 2.54) 2003 Modelled IHME
1.79 (1.20 - 2.53) 2002 Modelled IHME
1.79 (1.19 - 2.54) 2001 Modelled IHME
1.81 (1.21 - 2.55) 2000 Modelled IHME
1.83 (1.22 - 2.60) 1999 Modelled IHME
1.83 (1.23 - 2.58) 1998 Modelled IHME
1.83 (1.23 - 2.57) 1997 Modelled IHME
1.84 (1.25 - 2.60) 1996 Modelled IHME
1.84 (1.25 - 2.64) 1995 Modelled IHME
1.86 (1.27 - 2.65) 1994 Modelled IHME
1.89 (1.30 - 2.69) 1993 Modelled IHME
1.92 (1.32 - 2.73) 1992 Modelled IHME
1.93 (1.33 - 2.72) 1991 Modelled IHME
1.93 (1.34 - 2.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
191 (125 - 275) 2019 Modelled IHME
186 (123 - 265) 2018 Modelled IHME
180 (119 - 259) 2017 Modelled IHME
175 (116 - 249) 2016 Modelled IHME
172 (113 - 249) 2015 Modelled IHME
165 (109 - 239) 2014 Modelled IHME
159 (107 - 230) 2013 Modelled IHME
155 (104 - 223) 2012 Modelled IHME
150 (101 - 215) 2011 Modelled IHME
143 (96 - 205) 2010 Modelled IHME
135 (91 - 192) 2009 Modelled IHME
131 (89 - 185) 2008 Modelled IHME
127 (85 - 179) 2007 Modelled IHME
122 (81 - 173) 2006 Modelled IHME
117 (79 - 165) 2005 Modelled IHME
113 (76 - 160) 2004 Modelled IHME
109 (72 - 155) 2003 Modelled IHME
106 (71 - 150) 2002 Modelled IHME
103 (68 - 145) 2001 Modelled IHME
100 (67 - 142) 2000 Modelled IHME
99 (66 - 140) 1999 Modelled IHME
96 (64 - 134) 1998 Modelled IHME
92 (62 - 130) 1997 Modelled IHME
90 (61 - 127) 1996 Modelled IHME
87 (59 - 125) 1995 Modelled IHME
86 (58 - 122) 1994 Modelled IHME
84 (58 - 120) 1993 Modelled IHME
83 (57 - 118) 1992 Modelled IHME
81 (56 - 114) 1991 Modelled IHME
79 (55 - 111) 1990 Modelled IHME
74 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (16 - 32) 2019 Modelled IHME
24 (16 - 32) 2018 Modelled IHME
25 (16 - 32) 2017 Modelled IHME
25 (17 - 32) 2016 Modelled IHME
25 (17 - 33) 2015 Modelled IHME
25 (17 - 33) 2014 Modelled IHME
25 (17 - 33) 2013 Modelled IHME
25 (17 - 33) 2012 Modelled IHME
25 (17 - 33) 2011 Modelled IHME
25 (17 - 33) 2010 Modelled IHME
25 (17 - 33) 2009 Modelled IHME
25 (17 - 33) 2008 Modelled IHME
25 (17 - 34) 2007 Modelled IHME
26 (17 - 34) 2006 Modelled IHME
26 (18 - 34) 2005 Modelled IHME
26 (18 - 34) 2004 Modelled IHME
26 (18 - 34) 2003 Modelled IHME
26 (18 - 34) 2002 Modelled IHME
26 (18 - 35) 2001 Modelled IHME
26 (18 - 34) 2000 Modelled IHME
26 (18 - 34) 1999 Modelled IHME
26 (18 - 35) 1998 Modelled IHME
26 (18 - 35) 1997 Modelled IHME
26 (18 - 35) 1996 Modelled IHME
26 (18 - 35) 1995 Modelled IHME
26 (17 - 34) 1994 Modelled IHME
25 (17 - 34) 1993 Modelled IHME
25 (17 - 34) 1992 Modelled IHME
25 (17 - 33) 1991 Modelled IHME
25 (17 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
289
2019
(200 - 410)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
191
2019
(125 - 275)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
25 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines